Dr Shashank Tripathi
Associate Professor
| Microbiology and Cell Biology
Indian Institute of Science, Bangalore
Karnataka
Expertise:
Microbiology
51
Publications
0
Projects
4057
Scopus Citations
4438
CrossRef
7 Years 8 Months Total Experience
Scopus
4,057
Citations
24
h-index
CrossRef
4,438
Citations
24
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
No Data Found
There is currently nothing to display here.
Community & Membership
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
Personal Details
No Information Available
No information is available at this time.
Associate Professor
Jan 2025 – Present
Indian Institute of Science, Bangalore
| Microbiology and Cell Biology
Assistant Professor
Jan 2019 – Jan 2025
Indian Institute of Science, Bangalore
| Microbiology and Cell Biology
Medical and Health Sciences
Scholarly Work
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
A gene expression signature in nasopharyngeal swab samples for highly sensitive and specific covid-19 prognosis
INDIAN INSTITUTE OF SCIENCE
-
Patent No. :
IN202141033990
Filed :
28-01-2022
Published :
28-07-2023
Published
Antiviral Applications of Picolinic Acid and its Derivatives
Indian Institute of Science
-
Patent No. :
WO2022/157656
Filed :
20-01-2022
Published :
28-07-2022
Published
ANTIVIRAL APPLICATIONS OF PICOLINIC ACID AND ITS DERIVATIVES
INDIAN INSTITUTE OF SCIENCE
-
Patent No. :
US20220226292A1
Filed :
19-01-2022
Published :
21-07-2022
Published
Antiviral Applications of Picolinic Acid and its Derivatives
Indian Institute of Science
-
Patent No. :
US 2022-0226292 A1
Filed :
19-01-2022
Published :
21-07-2022
Published
Scholarly Publications
Infection of lung epithelial cells with pandemic 2009 a(H1N1) influenza viruses reveals isolate-specific differences in infectivity and host cellular responses
Innate Immune Subversion Strategies of Human Flaviviruses
Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples
Open AccessInfluenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs
Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection
Open AccessLive Visualization of Hemagglutinin Dynamics during Infection by Using a Novel Reporter Influenza A Virus
Open AccessMoving from empirical to rational vaccine design in the ‘Omics’ era
Open AccessThe ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type i interferon response
Open Access
Showing 1 to 8 of 51 publications